Report reveals pill mill-like operation in Trump White House

The White House medical unit has long distributed prescription and over-the-counter drugs, and even controlled substances, without record keeping, in keeping with a recent report by the U.S. Department of Defense, revealing that the pharmacy sometimes provided drugs to “ineligible White House employees.” . .

The bombing, which was revealed in a January report, detailed a rise in the variety of cases of negligence in the operation of the White House medical unit during Donald Trump’s presidency, but in addition mentioned some problems during Barack Obama’s term.

The former official described Trump’s White House as “awash in speed” and Xanax, in keeping with several news reports, where employees routinely took stimulants during late-night work sessions.

According to Rolling Stone, the anti-anxiety drug Xanax was also a well-liked and available drug through the Trump administration, and other prescription medications were also distributed. In fact, two individuals with direct knowledge of the situation recalled senior officials receiving Xanax from the medical department and sharing it with co-workers.

“It was a bit just like the Wild West. It was quite a loose affair. Whatever someone needs, we’re going to fulfill it,” one source said he said Rolling Stone.

Meanwhile, a federal investigation revealed that there have been “serious and systemic problems” in the White House Medical Branch’s pharmacy operations resulting from the unit’s failure to keep up pharmacy safety standards, Inspector General Robert P. Storch said in a news release.

The investigation was initiated following complaints to the Department of Defense Inspector General citing issues equivalent to inadequate record keeping and the overuse of brand-name drugs as a substitute of more cost effective generic drugs. The unit placed significant orders for drugs including fentanyl, morphine and ketamine.

In 2018, the Department of Defense received complaints that a senior military physician on the White House Medical Branch was engaging in inappropriate medical practices. The investigation included site visits, meetings with officials and interviews with greater than 120 people, including hospital administrators and military medical personnel, in keeping with the report.

Some of the complaints also concerned pharmacy practices and patient eligibility at department-run medical facilities in the National Capital Region.

The report found that the unit “dispensed prescription drugs, including controlled substances, to unqualified White House employees.” She also pointed to systemic problems related to the activities of pharmacies through the previous presidential administrations in 2009–2019. It found that the unit also did not keep proper records and sometimes distributed drugs to individuals who weren’t legally entitled to receive them.

Under the supervision of the Department of Defense, the White House Medical Branch consists of military physicians, physician assistants, registered nurses and other active-duty medical personnel.

U.S. Rep. Ronny Jackson, a Republican who currently represents Texas’ thirteenth District, was a physician in the Obama-Trump White House before he left in 2018.

Jackson spokesman he said NBC News reported that he was not the director of the White House medical division on the time many of the data for the report was provided.

A spokesman noted that in early 2019, Jackson was the president’s chief medical adviser under Trump, which involved health care policy, and had “no affiliation with or involvement in the provision of clinical care through the White House Medical Unit.”

But a Pentagon watchdog investigation into Jackson while he was White House physician uncovered inappropriate behavior, and the Navy demoted him from admiral to captain in 2022, in keeping with The Washington Post.

A Department of Defense report released in March 2021 cited two incidents in which Jackson improperly drank alcohol while on presidential trips while leading efforts to supply medical care and treatment to U.S. officials.